Evaluation of the impact of a nurse-led telephone follow-up on treatment compliance of patients treated from a locally advanced or metastatic non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation(s).The PARTAGE study.

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Study drug and medical condition

• Name of medicine:
  GIOTRIF
• Medical condition to be studied:
  EGFR gene mutation

  Lung cancer metastatic

Population studied

• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  500

Study design details

• Main study objective:
  To evaluate, during routine clinical practice, the impact of nurse-led telephone follow-up on overall patient treatment compliance with oral targeted therapy (cumulated dose* during the 3-month follow-up).
• Outcomes:
  The impact of nurse-led telephone follow-up on overall patient treatment compliance, Patient and health care professional 's satisfactionary, quality of life
• Data analysis plan:
  At the inclusion visit (D0), the investigator will ask the patient whether he would like to participate in the study and will obtain his written consent. Patients agreeing to participate will be randomised (3:1 ratio) and included in one of the following 2 groups:Group without `remote additional personalised nurse-led follow-up: patients will receive the healthcare given routinely by their medical team (100 patients).Group with `remote additional personalised nurse-led follow-up: patients will receive telephone calls from a nurse in addition to the healthcare given routinely by their medical team (300 patients).All the patients will be seen according to normal practice by the study medical team.Patients in the group with `remote additional personalised nurse-led follow-up will be contacted 8 times during the s